Jones Day advised Invirsa. Jones Day represented Invirsa, Inc. in the establishment of a global patent portfolio related to INV-102, a small molecule immune response modulator….
This content is for Standard 1 Year members only. LoginJoin Now
Author: Ambrogio Visconti
…
This content is for Standard 1 Year members only. LoginJoin Now